- Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine.
- Clinical evidence also suggests that the risk of getting a “breakthrough” infection gradually increases in the months after vaccination.
- Despite declines in antibody levels, other branches of the adaptive immune system appear to provide strong protection against severe infection and death.
- However, booster shots could protect the most vulnerable individuals, reduce transmission, and help suppress the emergence of new strains.
In the United States, the Food and Drug Administration (FDA)Trusted Source has approved third doses, or “boosters,” of the Pfizer-BioNTech COVID-19 vaccine for people over the age of 65 years.
It also approved boosters for people with health conditions that put them at risk of severe COVID-19 and for people whose jobs expose them to a high risk of infection, including healthcare workers and teachers.
The agency had already givenTrusted Source the green light to boosters for individuals with severely weakened immune systems, such as organ transplant patients.
But is there any evidence to justify a more widespread rollout of booster shots in the general population?
A recent study found that serum levels of antibodies against the spike protein of the virus, which it uses to gain entry to cells, start to wane around 12 weeks after the second dose of the Pfizer vaccine.
The researchers discovered that by 6 months after the second dose, median levels of these antibodies had fallen to around 7% of their peak level, with a range of 2–25%. The researchers say that this decline is expected.
Other workTrusted Source has shown that after having an mRNA-based vaccine against SARS-CoV-2, antibodies may not be circulating, but they are at peak activity within the lymph nodes by 12 weeks.
Cells that remember
At first glance, this appears to represent a worrying loss of immunity, but antibodies are only one branch of the body’s adaptive immune system.
The adaptive immune system also includes cells that remember past infections or vaccinations and swing into action if they encounter the same infectious agent again.
A recent preprint of a study reports that the number of immune cells known as memory B cells that recognize the virus actually increases 3–6 months after the second dose of the Pfizer or Moderna vaccine.
Remarkably, even though these vaccines use genetic material from the original variant of the virus, the B cells also recognized the Alpha, Beta, and Delta variants.
This is because the precursors of these B cells evolve over time in the body through a process of random mutation, which allows the mature cells to detect new variants of the virus as they arise.
The research also found two other types of immune cell primed to detect the virus in most individuals 6 months after their second dose of vaccine.
Known as helper T cells (CD4+ cells) and killer T cells (CD8+ cells), these help ramp up the immune response and destroy infected cells, respectively…
News
AI Transforms Drug Discovery With Faster, Safer Cancer Treatments
The new platform helped UC San Diego scientists synthesize 32 potential multi-target cancer drugs. Scientists at UC San Diego have developed a machine learning algorithm to simulate the time-consuming chemistry involved in the earliest phases of [...]
Nanotech opens door to future of insulin medication
An international team, led by researchers from Australia, have developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future. The researchers say the new insulin could [...]
COVID-19’s Impact on Child Development More Subtle Than Expected
Researchers at Johns Hopkins Children’s Center express that the study results offer a sense of reassurance, instilling “guarded optimism” regarding the developmental outcomes of young children who have been exposed to restrictions stemming from [...]
New Hope for Neurological Disorders: Scientists Have Discovered How an Essential Nutrient Enters the Brain
Researchers have discovered the process by which dietary choline crosses the blood-brain barrier. This breakthrough has potential applications in enhancing drug delivery to the brain for treating neurological disorders. A researcher from the University of [...]
Developing a tech platform for fast, robust series production of nanoparticles
Nucleic acid-based medications such as mRNA vaccines offer tremendous potential for medicine and are opening up new therapeutic approaches. These active ingredients must be enclosed inside nanoparticles to ensure that they get to where [...]
Unlocking Medical Mysteries: Tyche AI’s Revolutionary Insight Into Ambiguity
By providing plausible label maps for one medical image, the Tyche machine-learning model could help clinicians and researchers capture crucial information. In biomedicine, segmentation involves annotating pixels from an important structure in a medical [...]
Scientists Decode the Molecular Impact of Exercise
MoTrPAC examined the molecular effects of exercise on 2,600 volunteers, incorporating factors like age, race, and gender diversity. Building upon research in rats, MoTrPAC discovered over 35,000 biological molecules responding to endurance exercise and [...]
Prostate Cancer Breakthrough: Urine Test Avoids Unnecessary Biopsies
A study in JAMA Oncology reveals that MyProstateScore 2.0, a new urine test analyzing 18 genes, surpasses PSA in detecting significant prostate cancers and could reduce unnecessary biopsies by up to 42%. A new urine test [...]
Wake Up and Die: New Brain Cell Discovery Could Unlock Alzheimer’s Secrets
This uncommon process is more frequently observed in neurodegenerative diseases and could offer insights into disease mechanisms. According to a new study published in PLOS Biology by Kim Hai-Man Chow and colleagues from the Chinese University [...]
Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathways
Researchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic processes behind Alzheimer’s disease, leading to potential new strategies for treatment. Alzheimer’s disease, the most common type of dementia, significantly impairs [...]
Cambridge Scientists Discover Simple “Twist” That Supercharges Clean Fuel Generation
Scientists have discovered a method to super-charge the ‘engine’ of sustainable fuel generation – by giving the materials a little twist. The researchers, led by the University of Cambridge, are developing low-cost light-harvesting semiconductors that power devices [...]
Completely New Use Discovered – This Traditional Herb Has Remarkable Nerve Regenerative Properties
Blessed thistle (Cnicus benedictus), a member of the Asteraceae family, thrives in our climate. This plant has been utilized for centuries as a medicinal herb, often consumed as an extract or tea to support [...]
Scientists study lipids cell by cell, making new cancer research possible
Imagine being able to look inside a single cancer cell and see how it communicates with its neighbors. Scientists are celebrating a new technique that lets them study the fatty contents of cancer cells, [...]
Antibiotic Breakthrough: Revolutionary Chinese Study Paves Way for Superbug Defeating Drugs
New research reveals that fluorous lipopetides act as highly effective antibiotics. Bacterial infections resistant to multiple drugs, which no existing antibiotics can treat, represent a significant worldwide challenge. A research group from China has [...]
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists clear a potential path toward earlier treatment for a disease that affects nearly 1,000,000 people in the United States. By Levi Gadye In a discovery that could hasten treatment for patients with multiple [...]
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
A study reveals that a new sequencing technique, tARC-seq, can accurately track mutations in SARS-CoV-2, providing insights into the rapid evolution and variant development of the virus. The SARS-CoV-2 virus that causes COVID has the unsettling [...]
